Status:
COMPLETED
Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement
Lead Sponsor:
University Hospital, Caen
Conditions:
Thromboembolism
Arthroplasty Replacement, Knee
Eligibility:
All Genders
46+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether stopping Low Molecular Weight Heparin (LMWH) thromboprophylaxis is safe after total knee joint replacement. The investigators select patients without ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- First total knee joint replacement
- Signed informed consent
- Non-inclusion Criteria:
- History of venous thromboembolism/major bleeding/Heparin induced thrombopenia
- Active cancer
- Long-term anticoagulation
Exclusion
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2007
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT00362492
Start Date
June 1 2004
End Date
June 1 2007
Last Update
October 28 2010
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Alençon
Alençon, France, 61014
2
Hospital University Angers
Angers, France
3
Clinique du Cèdre
Bois-Guillaume, France, 76230
4
Caen University hospital
Caen, France, 14033